The civic record
Read. Follow. Verify.Utah extends prescription refill validity to two years and revises pharmacy substitution rules
Last action · March 17, 2026: Governor SignedSponsors: Ray Ward and 1 other
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
What This Bill Does
Utah extends the maximum refill period for authorized prescriptions from one year to two years, removes a requirement for pharmacies to notify prescribers of medication substitutions for prescriptions exceeding 30 days unless treating seizure disorders, and establishes requirements for s issued by the Department of Health and Human Services.
Patients filling authorized prescriptions now have an extended two-year window before needing a new prescription from their practitioner, reducing renewal frequency for chronic or long-term medications.
Who It Affects
Groups the bill's text affects, as described in the record. Being affected is not a position for or against it.
patients
Patients benefit from an extended two-year refill window and potential cost savings from therapeutically similar drug substitutions.
pharmacists
Pharmacists are granted broader substitution authority and are relieved from certain prescriber notification requirements for long-term prescriptions.
prescribing practitioners
Practitioners experience changes in notification requirements when pharmacists make therapeutically similar drug substitutions for prescriptions exceeding 30 days.
Key Facts
You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.
Frequently Asked Questions
How long are prescription refills valid under the new law?
Does a pharmacist still need to notify my doctor if they substitute a medication for a prescription longer than 30 days?
What medications must be considered first when creating the therapeutically similar drug list?
What else do you want to know?
News Coverage
FDA’s top drug regulator ousted amid agency upheaval
Tracy Beth Høeg has been removed from her role as the acting director of the FDA's Center for Drug Evaluation and Research. This departure marks the fifth leadership change for the division since the start of the year.
FDA blocked studies finding Covid and shingles vaccines safe, HHS official says
A Department of Health and Human Services (HHS) spokesperson confirmed that the FDA blocked the publication of several taxpayer-funded studies that concluded Covid-19 and shingles vaccines were safe. The agency stated the studies were withdrawn due to methodological concerns, while critics argue the move reflects a pattern of suppressing data that supports vaccine safety.
Bias ratings based on AllSides / Media Bias/Fact Check
Follow the record
Votes, people, money & the original sourceWhere This Stands
Current status: Signed into law.
Procedural history
49 actions- Mar 17, 2026Lieutenant Governor's office for filingEnrolledGovernor Signed
- Mar 11, 2026HouseHouse/ to Governor
- Mar 11, 2026HouseHouse/ received enrolled bill from Printing
- Mar 5, 2026HouseHouse/ enrolled bill to Printing
- Mar 5, 2026Clerk of the HouseEnrolled Bill Returned to House or Senate
- Feb 25, 2026Legislative Research and General Counsel / EnrollingDraft of Enrolled Bill Prepared
Show 43 earlier actions
- Feb 25, 2026Legislative Research and General Counsel / EnrollingBill Received from House for Enrolling
- Feb 20, 2026HouseHouse/ signed by Speaker/ sent for enrolling
- Feb 20, 2026HouseHouse/ received from Senate
- Feb 20, 2026SenateSenate/ to House
- Feb 20, 2026SenateSenate/ signed by President/ returned to House
- Feb 20, 2026SenateSenate/ received from House
- Feb 20, 2026HouseHouse/ to Senate
- Feb 20, 2026HouseHouse/ concurs with Senate amendment
- Feb 19, 2026HouseHouse/ placed on Concurrence Calendar
- Feb 19, 2026HouseHouse/ received from Senate
- Feb 19, 2026SenateSenate/ to House with amendments
- Feb 19, 2026SenateFloorSenate/ passed 3rd reading
- Feb 19, 2026SenateSenate/ 3rd reading
- Feb 18, 2026SenateFloorSenate/ passed 2nd reading
- Feb 18, 2026SenateSenate/ floor amendment
- Feb 18, 2026SenateSenate/ 2nd reading
- Feb 17, 2026SenateSenate/ placed on 2nd Reading Calendar
- Feb 17, 2026SenateSenate/ committee report favorable
- Feb 12, 2026SenateSenate Comm - Favorable Recommendation
- Feb 10, 2026SenateCommitteeSenate/ to standing committee
- Feb 6, 2026SenateIntroducedSenate/ 1st reading (Introduced)
- Feb 6, 2026SenateSenate/ received from House
- Feb 6, 2026HouseHouse/ to Senate
- Feb 6, 2026HouseFloorHouse/ passed 3rd reading
- Feb 6, 2026HouseHouse/ 3rd reading
- Jan 29, 2026ReleasedLFA/ fiscal note publicly available for HB0264S01
- Jan 28, 2026HouseHouse/ 2nd reading
- Jan 28, 2026HouseHouse/ comm rpt/ substituted
- Jan 28, 2026Version SponsorLFA/ fiscal note sent to sponsor for HB0264S01
- Jan 27, 2026HouseHouse Comm - Favorable Recommendation
- Jan 27, 2026HouseHouse Comm - Substitute Recommendation
- Jan 27, 2026Legislative Fiscal AgencyLFA/ bill sent to agencies for fiscal input for HB0264S01
- Jan 27, 2026Legislative Fiscal AnalystLFA/ bill assigned to staff for fiscal analysis for HB0264S01
- Jan 23, 2026HouseCommitteeHouse/ to standing committee
- Jan 20, 2026HouseIntroducedHouse/ 1st reading (Introduced)
- Jan 20, 2026HouseHouse/ received fiscal note from Fiscal Analyst
- Jan 20, 2026HouseHouse/ received bill from Legislative Research
- Jan 17, 2026ReleasedLFA/ fiscal note publicly available for HB0264
- Jan 17, 2026Version SponsorLFA/ fiscal note sent to sponsor for HB0264
- Jan 15, 2026Legislative Fiscal AgencyLFA/ bill sent to agencies for fiscal input for HB0264
- Jan 15, 2026Legislative Fiscal AnalystLFA/ bill assigned to staff for fiscal analysis for HB0264
- Jan 15, 2026Legislative Research and General CounselNumbered Bill Publicly Distributed
- Jan 15, 2026Legislative Research and General CounselBill Numbered but not Distributed
Version history
Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.
View official text →Voting Record
House/ passed 3rd reading
Total
75
- Yes
- 69
- No
- 0
- Present
- 0
- Not voting
- 6
- Abstain
- 0
How they voted (1)
Lobbying Activity
No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.
Full breakdown
Who this bill affects and the strongest case for and against it, written only from the bill’s own text.
Sponsors
Connected Entities
Sources
le.utah.gov
Analysis Score
0–100- Significance65How much this matters to a regular citizen
- Controversy10Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz25Current news / social attention level
Publisher tools